Esperion Therapeutics
ESPR
#6091
Rank
NZ$1.61 B
Marketcap
NZ$6.83
Share price
3.42%
Change (1 day)
72.36%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: NZ$1.61 Billion

As of December 2025 Esperion Therapeutics has a market cap of NZ$1.61 Billion. This makes Esperion Therapeutics the world's 6091th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$1.61 B103.32%
2024NZ$0.79 B48.15%
2023NZ$0.53 B-25.64%
2022NZ$0.72 B62.19%
2021NZ$0.44 B-52.26%
2020NZ$0.93 B-61.64%
2019NZ$2.43 B32.35%
2018NZ$1.83 B-24.26%
2017NZ$2.42 B495.78%
2016NZ$0.40 B-44.34%
2015NZ$0.73 B-30.25%
2014NZ$1.04 B309.35%
2013NZ$0.25 B

End of Day market cap according to different sources

On Dec 20th, 2025 the market cap of Esperion Therapeutics was reported to be:

NZ$1.63 Billion
by Nasdaq info icon info icon
NZ$1.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$5.61 B 246.90%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$20.42 B 1,160.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$248.96 B 15,272.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$141.48 B 8,636.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$7.60 B 369.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ$0.73 B-54.36%๐Ÿ‡บ๐Ÿ‡ธ USA